Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial — Journal of Clinical Psychiatry (2025)• Drug: lumateperonePMID
- Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial — American Journal of Psychiatry (2025)• Drug: lumateperonePMID
- Lumateperone monotherapy for bipolar depression: a randomized, placebo-controlled clinical trial — Journal of Clinical Psychiatry (2021)• Drug: lumateperoneDOIPMID
- Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial — JAMA Psychiatry (2020)• Drug: lumateperoneDOIPMID